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DNA analyses of the cystic fibrosis
transmembrane conductance regulator
(CFTR) gene in Japanese patients with
idiopathic chronic pancreatitis (ICP) were
performed to determine the relationship
between the CFTR mutation and ICP. The
study included patients with alcoholic
pancreatitis (n = 20), patients with ICP
(n = 20) and healthy volunteers (controls;
n = 110). The poly-T region in intron 8 of
the CFTR gene was analysed by direct
sequencing. The CFTR coding region
was screened using single-strand
conformational polymorphism and direct
sequencing. In the controls, frequencies of
the 5T genotype and 5T allele were 4.5%
and 3.6%, respectively. The frequency of
the 5T genotype was significantly higher
in the ICP group (20%) versus controls,
but was not significantly different in
alcoholic chronic pancreatitis patients
(5%). Thus, the CFTR gene mutation,
especially the 5T genotype, appears to
have some relationship to ICP prevalence
in Japanese patients independent of cystic
fibrosis.
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Introduction
Chronic pancreatitis is clinically
characterized by acinar cell degeneration
and fibrosis that may lead to the destruction
of exocrine and endocrine organ functions,1,2
and results in maldigestion and diabetes
mellitus. Several underlying conditions
appear to play a role in the pathogenesis of
chronic pancreatitis, however the most
common types of chronic pancreatitis are
alcohol-related and idiopathic.3
A strong association between mutations
in the cystic fibrosis transmembrane
conductance regulator (CFTR) gene and
idiopathic chronic pancreatitis (ICP) has
been reported.4 Cystic fibrosis is the most
common autosomal recessive disease in
Caucasians, affecting 1 in 1600 to 1 in 2500
live births and corresponding to a carrier
frequency of about 1 in 25.5 In contrast,
cystic fibrosis is rare among Asian
populations.6 In Japan, there have been
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approximately 130 cases of cystic fibrosis
reported in the literature during the last five
decades, with an estimated incidence of 1 in
350 000 live births.7 It is thought that the
frequency difference between the Japanese
and Caucasian populations might be due to
a lack of Japanese population exposure to
the founder gene effect of CFTR.6,7
Since it was anticipated that some of the
common mutations found in Western
countries may not have not been detected in
Japanese cases, the present study was not
designed to examine disease-causing
mutations but, rather, to investigate
predisposing genetic factors. Variations in
the poly-T sequence in intron 8 of the CFTR
gene can affect the function of this gene and
the 5T allelic variant has been shown to
decrease CFTR gene function even when
heterozygous.8,9 The aims of the present
study were, therefore, to confirm the
frequency of the 5T genotype in the Japanese
population, to evaluate its frequency in
Japanese patients with ICP and alcoholic
pancreatitis, and to examine mutations of
the CFTR gene and the trypsinogen-encoding




This study was approved by the Medical
Ethics Committee of Kanazawa University
and written informed consent to carry out
genetic analysis was obtained from each
patient and the family.
Consecutive Japanese patients who visited
Kanazawa University Hospital (Kanazawa,
Japan) with either ICP or alcoholic
pancreatitis were enrolled in the study. The
control group comprised healthy volunteers.
The diagnosis of chronic pancreatitis was
based on visible calculi on X-ray film or
unequivocally abnormal findings from
endoscopic retrograde cholangiopancreatog-
raphy. The criterion for diagnosis of
alcoholic chronic pancreatitis was ethanol
intake of ≥ 60 g/day for ≥ 2 years before
manifestation of pancreatitis. The diagnosis
of ICP was performed by exclusion of
diseases of the biliary system, alcoholism,
autoimmune disease, abnormalities of the
pancreatic ducts, drug-induced pancreatitis,
trauma, or autosomal-dominant pancreatitis.
ANALYSIS OF THE POLY-T REGION
IN INTRON 8 OF CFTR
Genomic DNA was isolated from peripheral
blood. The poly-T region in intron 8 of the
CFTR gene was amplified by polymerase
chain reaction (PCR) and direct sequencing
was performed using a non-radioactive
sequencing method (Sequencing High Plus™
kit; Toyobo, Osaka, Japan).
ANALYSIS OF CODING REGIONS
AND SPLICE SITES OF CFTR AND
PRSS1
Each exon was amplified by PCR using
specific primers (Tables 1 and 2), and
screened using the single-strand
conformational polymorphism (SSCP)
method.10 When abnormal bands were
detected by SSCP, the PCR products were
sequenced using a BigDye® Terminator
Version 3.1 Cycle Sequencing Kit and ABI
PRISM® 3100/Avant Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA).
RESTRICTION FRAGMENT LENGTH
POLYMORPHISM
Restriction fragment length polymorphism
(RFLP) was used to confirm the detection of
mis-sense mutations in the CFTR gene
according to the method of Botstein et al.11
STATISTICAL ANALYSIS
The χ2 test was performed to assess the
Exon Forward primer Reverse primer
Exon 1F 5′-GAGTGGCCAAACATAGCCAG-3′ 5′-GCATTTGTCGGCCAGGAACG-3′
Exon 2F 5′-CGCCACCCCTAACATGCTAT-3′ 5′-CTCTCCCAGGCAGACTGGCC-3′
Exon 3F 5′-AAGGTGGGATAGGTGCCCTG-3′ 5′-GGATGGAGGGAAGTAGAAGGACT-3′
Exon 4F 5′-GACCCACATTTCTACTTCCTTTGATC-3′ 5′-CTCAGCATGGGAAGGGTTGG-3′
Exon 5F 5′-TATTCCTCCTCCATCTCTCCATAC-3′ 5′-CAGTGTGAAGGAGTGAGAGG-3′
TABLE 2:
Polymerase chain reaction primers used for amplification of the protease serine 1 (PRSS1)
gene
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Exon Forward primer Reverse primer
Exon 1F 5′-TTGGCATTAGGAGCTTGAGC-3′ 5′-ACGTGTCTTTCCGAAGCTCG-3′
Exon 2F 5′-CATAATTTTCCATATGCCAG-3′ 5′-CACCATACTTGGCTCCTATT-3′
Exon 3F 5′-CTTGGGTTAATCTCCTTGGA-3′ 5′-ATTCACCAGATTTCGTAGTC-3′
Exon 4F 5′-CTTGTGTTGAAATTCTCAGGG-3′ 5′-CAGCTCACTACCTAATTTATGA-3′
Exon 5F 5′-GAGAAGATAGTAAGCTAGAT-3′ 5′-TATTAACAACAGGCTAAGGT-3′
Exon 6aF 5′-ACACCTGTTTTTGCTGTGCT-3′ 5′-CTATGCATAGAGCAGTCCTG-3′
Exon 6bF 5′-GGAGGCATTTACCAAACAGT-3′ 5′-ATATGAGGTGGAAGTCTACC-3′
Exon 7AF 5′-TTCCATTCCAAGATCCCT-3′ 5′-AACACCACAAAGAACCCTGA-3′
Exon 7BF 5′-AAGGCAGCCTATGTGAGATA-3′ 5′-TGTCCAGAGAAATGCTAGGA-3′
Exon 8F 5′-TCCTAGTGCTTGGCAAATTA-3′ 5′-ACAGTTAGGTGTTTAGAGCA-3′
Exon 9F 5′-AAAATATCTGACAAACTCATC-3′ 5′-AAAATACCTTCCAGCACTAC-3′
Exon 10F 5′-AGTGAATCCTGAGCGTGATT-3′ 5′-GTGTGAAGGGTTCATATGCA-3′
Exon 11F 5′-CAACTGTGGTTAAAGCAATAGTGT-3′ 5′-GCACAGATTCTGAGTAACCATAAT-3′
Exon 12F 5′-TGACCAGGAAATAGAGAGGA-3′ 5′-TATGATGGGACAGTCTGTCT-3′
Exon 13AF 5′-GAATTCACAAGGTACCAATT-3′ 5′-CTGTAGATTTTGGAGTTCTG-3′
Exon 13BF 5′-TTTGCATGAAGGTAGCAGCT-3′ 5′-GGGAGTCTTTTGCACAATGG-3′
Exon 13CF 5′-ACTGGAGAGTTTGGGGAAAA-3′ 5′-GCCAGTGACACTTTTCGTGT-3′
Exon 13DF 5′-GTCCTGAACCTGATGACACA-3′ 5′-TGAAATACCCCCAAGCGATG-3′
Exon 14aF 5′-AAAAGGTATGCCACTGTTAA-3′ 5′-GTATACATCCCCAAACATTCT-3′
Exon 14bF 5′-GGGAGGAATAGGTGAAGATG-3′ 5′-CCACTACCATAATGCTTGGG-3′
Exon 15AF 5′-GTAAGTAACTTTGGCTGCCA-3′ 5′-ATTAGAGTATGCACCAGTGG-3′
Exon 15BF 5′-AGTAGCCGACACTTTGCTTG-3′ 5′-CCTATTGATGGTGGATCAGC-3′
Exon 16F 5′-GGGTTCTGAATGCGTCTACT-3′ 5′-GACAGGACTTCAACCCTCAA-3′
Exon 17aF 5′-TTGTCCACTTTGCAATGTGA-3′ 5′-TACAAGATGAGTATCGCACA-3′
Exon 17bAF 5′-AAGAATGGCACCAGTGTGAA-3′ 5′-CTCATTTGGAACCAGCGCAG-3′
Exon 17bBF 5′-AGCCTTACTTTGAAACTCTG -3′ 5′-GATAACCTATAGAATGCAGC-3′
Exon 18F 5′-GCCCTAGGAGAAGTGTGAAT-3′ 5′-ACAGATACACAGTGACCCTC-3′
Exon 19F 5′-CCGACAATAACCAAGTGAC-3′ 5′-GCTAACACATTGCTTCAGGC-3′
Exon 20F 5′-TCACAGAAGTGATCCCATCA-3′ 5′-TTCTGGCTAAGTCCTTTTGC-3′
Exon 21F 5′-GATGGTAAGTACATGGGTGT-3′ 5′-TGGTATGAGTTACCCCTTTC-3′
Exon 22F 5′-GCTTTCAGAACTCCTGTGTT-3′ 5′-CTGTTCCTGTGCTATTA-3′
Exon 23F 5′-CTGATTGTGCGTAACGCTAT-3′ 5′-AGGGCAATGAGATCTTAAGT-3′
Exon 24F 5′-CATAGAAGAGAACAAATGGC-3′ 5′-GTGACTGTCCCACGAGCTCC-3′
TABLE 1:
Polymerase chain reaction primers used for amplification of cystic fibrosis transmembrane
conductance regulator (CFTR) gene
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frequency of the 5T genotype between
patients and controls. A P-value < 0.05 was
considered to be statistically significant. Stat
View® version 5.0 (SAS Institute, Cary, USA)
was used for data analysis.
Results
CLINICAL CHARACTERISTICS
A total of 40 patients with chronic
pancreatitis were enrolled in the study: 20
were diagnosed with ICP (four males, 16
females, mean ± SD age 42.6 ± 10.2 years)
and 20 with alcoholic chronic pancreatitis (17
males, three females, mean ± SD age 53.2 ±
12.2 years). The control group comprised 110
healthy volunteers (56 males, 44 females).
DNA STUDIES
Following PCR amplification and direct
sequencing of the poly-T region in intron 8 of
the CFTR gene, genotypes with the 5T and 7T
alleles were identified (Fig. 1). Genotypes
that had at least one 5T allele were defined
as a 5T genotype. The frequencies of the 5T
genotype and 5T allele in the control group
were 4.5% and 3.6%, respectively. The
frequencies for the 5T allele in the ICP and
alcoholic chronic pancreatitis patients were
12.5% and 5.0%, respectively. The frequency
of the 5T genotype in ICP patients was
20.0%, which was significantly higher than
in the control group (P = 0.012). In contrast,
the frequency of the 5T genotype in alcoholic
chronic pancreatitis patients was 5.0% and
was not significantly different from the
control group (Table 3). In this study, there
were three patients with early onset chronic
pancreatitis, i.e. diagnosed at < 30 years of
age. All were idiopathic and two had the 5T
genotype. This study was unable to show the
frequency of the 5T genotype in alcoholic
chronic pancreatitis patients to be
statistically significantly different from that
in the IPC group.
When the CFTR coding regions of patients
with ICP were screened, a mis-sense
mutation was detected in one allele in one
patient: a C-to-T substitution at position
4353 of the cDNA, which led to one amino
acid substitution of arginine to tryptophan
at codon 1453 (Arg1453Trp) (Fig. 2). This
result was confirmed by performing RFLP.
This mutation created a Bsr 1 digestion site
(Bsr 1 restriction fragments are shown in Fig.
3) in ICP patients but it was not detected in
the 50 control subjects.
FIGURE 1: The poly-T region in
intron 8 of the cystic fibrosis
transmembrane conductance
regulator (CFTR) gene amplified
by polymerase chain reaction and
analysed by a direct sequencing
method showed genotypes with
at least one 5T allele, which were
defined as the 5T genotype; the
9T allele was not detected in this
study. Bars signify the location of
the poly-T region.
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The PRSS1 coding regions of the 20
patients with ICP were also screened, but no
mutation was detected.
Discussion
Alcohol is one of the major causes of
pancreatitis. Since only a minority of
drinkers develops pancreatitis, studies have
sought to identify factors that may increase
susceptibility to the disease, however, so far
no susceptibility factor has been identified.12
The present study examined the poly-T
genotype frequencies in intron 8 of the CFTR
gene; however, no difference between the 5T
genotype frequencies of patients with
alcoholic chronic pancreatitis and healthy
control subjects was observed. Studies on the
acinar cell itself as the principal site for
ethanol-related damage have been carried
out13,14 and have also investigated the
molecular mechanism of alcoholic chronic
pancreatitis.12 Further studies in these areas
may help to resolve the factors that affect
susceptibility to pancreatitis.
In the present study, the frequency of the
5T genotype in ICP was significantly higher
TABLE 3:
Frequency of the 5T genotype in patients with chronic pancreatitis compared with healthy
control subjects
Control subjects Alcoholic pancreatitis Idiopathic pancreatitis
(n = 110) (n = 20) (n = 20)
5T genotype 4.5% (n = 5) 5.0% (n = 1) 20.0% (n = 4)*
*P = 0.012 (χ2-test) versus control subjects; other between-group comparisons were not statistically
significant (P > 0.05).
FIGURE 2: A mis-sense mutation in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene was detected in one allele in one patient: a C-to-T substitution
at position 4353 of the cDNA, which led to one amino acid substitution of arginine
to tryptophan at codon 1453 (Arg1453Trp)
Pro His Arg Asn
Control
Pro His Trp Asn
Pro His Arg Asn
Patient
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than observed in healthy controls. Unlike the
healthy controls with the 5T genotype, those
patients with ICP who possessed the 5T
genotype did not show cystic fibrosis
symptoms. This suggests that the 5T
genotype has some relation to ICP prevalence
in Japanese patients, especially in young
patients, independent of cystic fibrosis.
The poly-T sequence in intron 8 has been
shown to affect the function of the CFTR gene.8
Allelic variants of the poly-T sequence are 5T,
7T and 9T, and the 5T genotype of intron 8 in
the CFTR gene can decrease the function of
CFTR even when heterozygous.8,9 The 5T
variant occurs in 5% of chromosomes in the
general population, and differs from the 7T
and 9T variants because it hinders splicing of
CFTR mRNA.8,9 The 5T allele reduces the
efficiency of exon 9 splicing,8,9 and this
abnormal splicing reduces the expression of
functional CFTR protein.8 For the purposes of
the present study in terms of genetic structure
and allelic frequency, it was assumed that the
frequency of the 5T genotype was not different
between Caucasian and Japanese populations
in evaluating whether there was any
relationship between the 5T genotype and
chronic pancreatitis. The CFTR coding region
of patients with ICP was also screened.
Autosomal-dominant pancreatitis was
excluded in the present study when the CFTR
mutations in patients with ICP were
examined and we found no mutation in the
PRSS1 coding regions of the patients with ICP.
Although it has been reported that 19% of
patients with a presumed diagnosis of ICP
have mutations in the cationic trypsinogen-
encoding gene, PRSS1,15 hereditary
pancreatitis differs from ICP in that it leads
to pancreatic adenocarcinoma with a
cumulative risk approaching 40%.16
A mis-sense mutation, Arg1453Trp, in the
CFTR gene was found in one patient with IPC
in the present study. This mutation reportedly
affects channel activity, but its overall effect
on CFTR function appears to be mild.17 As
this mis-sense mutation appeared in only
one patient, further studies are required to
establish whether this manifestation is
related to IPC or was merely coincidental.
In conclusion, mutation in the CFTR gene,
especially the 5T genotype, appears to be
FIGURE 3: The mis-sense mutation, Arg1453Trp, in the cystic fibrosis transmembrane
conductance regulator (CFTR) gene was confirmed using restriction fragment length
polymorphism (RFLP). Column 1 is a 20-base pair (bp) marker and column 2 is a 100
bp size marker. The mutation created a Bsr 1 digestion site: Bsr 1 restriction fragments
of 115 and 177 bp were detected using RFLP
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related to the prevalence of ICP in Japanese
patients, independent of the presence of
cystic fibrosis. No mutation of PRSS1 was
detected in Japanese patients with ICP. One
limitation of this study was the small sample
size of only 20 ICP patients and further
studies are needed to establish the
significance of the relationship between ICP
and CFTR in Japanese patients.
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